featured
Diagnostic Performance of 68Ga-RM2 PET–MRI vs MRI Alone in Patients With Biochemical Recurrence of Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
68Ga-RM2 PET-MRI versus MRI alone for evaluation of patients with biochemical recurrence of prostate cancer: a single-centre, single-arm, phase 2/3 imaging trial
Lancet Oncol 2024 Feb 26;[EPub Ahead of Print], H Duan, F Moradi, GA Davidzon, T Liang, H Song, AM Loening, S Vasanawala, S Srinivas, JD Brooks, S Hancock, A IagaruFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.